Product Information
METHYLPHENIDATE 2.5 MG CHEW TB is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.2991 per EA under NDC 64980022101. Its NADAC has been published 283 times since Mar 18, 2020.
FDA first approved this application on Nov 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980022101
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205756FDA Approved
11/7/2016
TE Code
AB
On Market Since
12/18/2018
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 2.5 MG CHEW TB has been published 283 times since Mar 18, 2020, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2991 per EA |
|---|---|
| All-time high | $2.0264 (Feb 2, 2022) |
| All-time low | $0.9884 (Apr 23, 2025) |
| 52-week high | $1.3175 |
| 52-week low | $1.0919 |
| Median price | $1.3005 |
| Average price | $1.4332 |
| Largest weekly change | +33.0% (May 19, 2021) |
| Weeks tracked | 283 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 2.5 MG CHEW TB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 2.5 MG CHEW TB, manufactured by Rising Pharma Holdings Inc., is $1.2991 per EA (NDC 64980022101), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 2.5 MG CHEW TB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 2.5 MG CHEW TB has declined 30.4%. It has been tracked across 283 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 2.5 MG CHEW TB?
Since Mar 18, 2020, the NADAC for METHYLPHENIDATE 2.5 MG CHEW TB has ranged from a low of $0.9884 (Apr 23, 2025) to a high of $2.0264 (Feb 2, 2022), with a median of $1.3005 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 2.5 MG CHEW TB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE 2.5 MG CHEW TB in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 2.5 MG CHEW TB?
METHYLPHENIDATE 2.5 MG CHEW TB (NDC 64980022101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.